{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,16]],"date-time":"2025-09-16T20:06:25Z","timestamp":1758053185233,"version":"3.44.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicalradiologyonline.net","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Radiology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.crad.2018.02.010","type":"journal-article","created":{"date-parts":[[2018,3,23]],"date-time":"2018-03-23T10:50:05Z","timestamp":1521802205000},"page":"677.e1-677.e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gadolinium-based relative contrast enhancement in primary sclerosing cholangitis: additional benefit for clinicians?"],"prefix":"10.1016","volume":"73","author":[{"given":"S.","family":"Keller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.K.","family":"Venkatesh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Avanesov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.M.","family":"Weinrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Zenouzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Schramm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.crad.2018.02.010_bib1","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1002\/hep.24247","article-title":"Incidence of primary sclerosing cholangitis: a systematic review and meta-analysis","volume":"53","author":"Molodecky","year":"2011","journal-title":"Hepatology"},{"issue":"9904","key":"10.1016\/j.crad.2018.02.010_bib2","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1016\/S0140-6736(13)60096-3","article-title":"Primary sclerosing cholangitis","volume":"382","author":"Hirschfield","year":"2013","journal-title":"Lancet"},{"issue":"1","key":"10.1016\/j.crad.2018.02.010_bib3","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/j.1572-0241.2006.00872.x","article-title":"Characterization, outcome, and prognosis in 273 patients with primary sclerosing cholangitis: a single center study","volume":"102","author":"Tischendorf","year":"2007","journal-title":"Am J Gastroenterol"},{"issue":"1","key":"10.1016\/j.crad.2018.02.010_bib4","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jhep.2008.08.013","article-title":"High lifetime risk of cancer in primary sclerosing cholangitis","volume":"50","author":"Claessen","year":"2009","journal-title":"J Hepatol"},{"issue":"9","key":"10.1016\/j.crad.2018.02.010_bib5","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1097\/MEG.0b013e3283554bbf","article-title":"Cholangiocarcinoma and dominant strictures in patients with primary sclerosing cholangitis: a 25-year single-centre experience","volume":"24","author":"Chapman","year":"2012","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.crad.2018.02.010_bib6","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1080\/003655202760373434","article-title":"Cholangiocarcinoma in primary sclerosing cholangitis: risk factors and clinical presentation","volume":"37","author":"Boberg","year":"2002","journal-title":"Scand J Gastroenterol"},{"issue":"2","key":"10.1016\/j.crad.2018.02.010_bib7","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jhep.2009.04.009","article-title":"EASL Clinical Practice Guidelines: management of cholestatic liver diseases","volume":"51","author":"European Association for the Study of the L","year":"2009","journal-title":"J Hepatol"},{"issue":"5","key":"10.1016\/j.crad.2018.02.010_bib8","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1002\/hep.29293","article-title":"IPSCSG MRIwgot. Recommendations on the use of MRI in PSC-A position statement from the International PSC study group","volume":"66","author":"Schramm","year":"2017","journal-title":"Hepatology"},{"issue":"1","key":"10.1016\/j.crad.2018.02.010_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0016-5107(98)70121-X","article-title":"Major early complications from diagnostic and therapeutic ERCP: a prospective multicenter study","volume":"48","author":"Loperfido","year":"1998","journal-title":"Gastrointest Endosc"},{"issue":"14","key":"10.1016\/j.crad.2018.02.010_bib10","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1056\/NEJM199504063321406","article-title":"Primary sclerosing cholangitis","volume":"332","author":"Lee","year":"1995","journal-title":"N Engl J Med"},{"issue":"Suppl. 2","key":"10.1016\/j.crad.2018.02.010_bib11","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1159\/000440823","article-title":"Diagnosis, differential diagnosis, and epidemiology of primary sclerosing cholangitis","volume":"33","author":"Ponsioen","year":"2015","journal-title":"Dig Dis"},{"issue":"10","key":"10.1016\/j.crad.2018.02.010_bib12","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1111\/j.1572-0241.2002.06038.x","article-title":"Sampling error and intraobserver variation in liver biopsy in patients with chronic HCV infection","volume":"97","author":"Regev","year":"2002","journal-title":"Am J Gastroenterol"},{"issue":"2","key":"10.1016\/j.crad.2018.02.010_bib13","doi-asserted-by":"crossref","first-page":"96","DOI":"10.7326\/0003-4819-118-2-199301150-00003","article-title":"Outcome of patients hospitalized for complications after outpatient liver biopsy","volume":"118","author":"Janes","year":"1993","journal-title":"Ann Intern Med"},{"issue":"2","key":"10.1016\/j.crad.2018.02.010_bib14","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1148\/radiol.10091953","article-title":"Primary sclerosing cholangitis: meta-analysis of diagnostic performance of MR cholangiopancreatography","volume":"256","author":"Dave","year":"2010","journal-title":"Radiology"},{"issue":"1","key":"10.1016\/j.crad.2018.02.010_bib15","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1148\/radiology.215.1.r00ap2671","article-title":"Primary sclerosing cholangitis: evaluation with MR cholangiography\u2014a case\u2013control study","volume":"215","author":"Fulcher","year":"2000","journal-title":"Radiology"},{"issue":"6","key":"10.1016\/j.crad.2018.02.010_bib16","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1007\/s00261-011-9821-y","article-title":"Assessment of wall inflammation and fibrosis in Crohn's disease: value of T1-weighted gadolinium-enhanced MR imaging","volume":"37","author":"Makanyanga","year":"2012","journal-title":"Abdom Imaging"},{"issue":"6","key":"10.1016\/j.crad.2018.02.010_bib17","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/S0033-8389(02)00044-1","article-title":"Imaging of chronic pancreatitis","volume":"40","author":"Remer","year":"2002","journal-title":"Radiol Clin North Am"},{"issue":"5","key":"10.1016\/j.crad.2018.02.010_bib18","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1002\/jmri.20192","article-title":"Reversible heterogeneous arterial phase liver perfusion associated with transient acute hepatitis: findings on gadolinium-enhanced MRI","volume":"20","author":"Martin","year":"2004","journal-title":"J Magn Reson Imaging"},{"issue":"4","key":"10.1016\/j.crad.2018.02.010_bib19","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.2214\/ajr.173.4.10511174","article-title":"Primary sclerosing cholangitis: MR imaging findings with pathologic correlation","volume":"173","author":"Revelon","year":"1999","journal-title":"AJR Am J Roentgenol"},{"issue":"1","key":"10.1016\/j.crad.2018.02.010_bib20","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1097\/00004728-199701000-00012","article-title":"Intrahepatic cholangiocarcinoma: MRI and pathologic correlation in 14 patients","volume":"21","author":"Vilgrain","year":"1997","journal-title":"J Comput Assist Tomogr"},{"issue":"3","key":"10.1016\/j.crad.2018.02.010_bib21","doi-asserted-by":"crossref","first-page":"819","DOI":"10.2214\/ajr.181.3.1810819","article-title":"Cholangiocarcinoma: morphologic classification according to growth pattern and imaging findings","volume":"181","author":"Lim","year":"2003","journal-title":"AJR Am J Roentgenol"},{"issue":"4","key":"10.1016\/j.crad.2018.02.010_bib22","first-page":"413","article-title":"Terminology of liver anatomy and liver resections: coming to grips with hepatic Babel","volume":"184","author":"Strasberg","year":"1997","journal-title":"J Am Coll Surg"},{"issue":"5","key":"10.1016\/j.crad.2018.02.010_bib23","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.crad.2013.12.008","article-title":"Diagnostic workup of primary sclerosing cholangitis: the benefit of adding gadoxetic acid-enhanced T1-weighted magnetic resonance cholangiography to conventional T2-weighted magnetic resonance cholangiography","volume":"69","author":"Nolz","year":"2014","journal-title":"Clin Radiol"},{"issue":"2","key":"10.1016\/j.crad.2018.02.010_bib24","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1002\/hep.23294","article-title":"Diagnosis and management of primary sclerosing cholangitis","volume":"51","author":"Chapman","year":"2010","journal-title":"Hepatology"},{"issue":"9935","key":"10.1016\/j.crad.2018.02.010_bib25","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1016\/S0140-6736(13)61903-0","article-title":"Cholangiocarcinoma","volume":"383","author":"Razumilava","year":"2014","journal-title":"Lancet"},{"issue":"7","key":"10.1016\/j.crad.2018.02.010_bib26","first-page":"685","article-title":"Primary sclerosing cholangitis: clinical presentation, natural history and prognostic variables: an Italian multicentre study. The Italian PSC Study Group","volume":"8","author":"Okolicsanyi","year":"1996","journal-title":"Eur J Gastroenterol Hepatol"},{"issue":"9","key":"10.1016\/j.crad.2018.02.010_bib27","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1007\/s10620-005-2927-8","article-title":"The value of serum CA 19-9 in predicting cholangiocarcinomas in patients with primary sclerosing cholangitis","volume":"50","author":"Levy","year":"2005","journal-title":"Dig Dis Sci"},{"issue":"6","key":"10.1016\/j.crad.2018.02.010_bib28","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/S1665-2681(19)31298-0","article-title":"Noninvasive assessment of hepatic fibrosis using gadoxetate-disodium-enhanced 3T MRI","volume":"12","author":"Jang","year":"2013","journal-title":"Ann Hepatol"},{"issue":"16","key":"10.1016\/j.crad.2018.02.010_bib29","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.4254\/wjh.v7.i16.1987","article-title":"Focal liver lesions: practical magnetic resonance imaging approach","volume":"7","author":"Matos","year":"2015","journal-title":"World J Hepatol"},{"issue":"9","key":"10.1016\/j.crad.2018.02.010_bib30","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/S0730-725X(98)00135-0","article-title":"Cholangiocarcinoma: spectrum of appearances on MR images using current techniques","volume":"16","author":"Worawattanakul","year":"1998","journal-title":"Magn Reson Imaging"},{"issue":"6","key":"10.1016\/j.crad.2018.02.010_bib31","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.2214\/ajr.172.6.10350284","article-title":"Primary sclerosing cholangitis: MR imaging features","volume":"172","author":"Ito","year":"1999","journal-title":"AJR Am J Roentgenol"}],"container-title":["Clinical Radiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926018300916?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0009926018300916?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,14]],"date-time":"2025-09-14T16:38:01Z","timestamp":1757867881000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0009926018300916"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S0009926018300916"],"URL":"https:\/\/doi.org\/10.1016\/j.crad.2018.02.010","relation":{},"ISSN":["0009-9260"],"issn-type":[{"type":"print","value":"0009-9260"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gadolinium-based relative contrast enhancement in primary sclerosing cholangitis: additional benefit for clinicians?","name":"articletitle","label":"Article Title"},{"value":"Clinical Radiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.crad.2018.02.010","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Royal College of Radiologists. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}